Now showing items 1-6 of 6
In situ expression of mononuclear cell markers and interleukin-2 receptor in renal allograft biopsies of acute rejection and borderline cases
(Renal Failure, 2007-01-01) [Artigo]
The correct diagnosis of renal allograft rejection may be difficult using only clinical and/or histopathological criteria. Immunological assays should be considered in order to evaluate the phenotype of inflammatory ...
The role of myofibroblasts and interstitial fibrosis in the progression of membranous nephropathy
(Renal Failure, 2004-09-15) [Artigo]
Renal interstitial fibrosis has been observed in a large number of nephropathies and contributes to the progressive deterioration of renal function. Myofibroblasts have been implicated in the reparative process of tissue ...
The hemolytic uremic syndrome as a complication of adriamycin nephropathy
(Renal Failure, 1998-08-13) [Artigo]
Rats treated with two injections of adriamycin (week 0 and week 12) developed glomerusclerosis and severe tubulointerstitial lesions as described in the literature. In addition, a number of glomerular alterations were ...
Mononuclear inflammatory infiltrate and microcirculation injury in acute rejection: Role in renal allograft survival
(Renal Failure, 2013-05-22) [Artigo]
This study aimed at investigating associations between monocytes/ macrophages (Mo) infiltration and three important criteria associated with acute antibody-mediated rejection: C4d staining, microcirculation injury, and ...
Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma
(Cytopathology, 2013-02-01) [Artigo]
Aims: To evaluate the reliability of fine needle aspirate cell blocks in the assessment of oestrogen receptor (ER), progesterone receptor (PR) and HER-2/neu proteins by immunohistochemistry in comparison with surgical ...
Effect of allopurinol in the course of adriamycin induced nephropathy
(Renal Failure, 1999-04-06) [Artigo]
The role of superoxide in adriamycin-induced nephropathy (single dose; i.v. 3 mg/kg) has been studied by blocking superoxide synthesis through the administration of allopurinol (500 mg/L in drinking water). In Experiment ...